Brain Imaging and HIV-Related Brain Disorders

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

Recruiting Phase 1 Phase 2 Interventional Study
HIV Associated Neurocognitive Disorder HIV Dementia HIV Encephalitis Healthy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Basic Science
Participants needed
70 (estimated)
Sponsor
Yale University · Other
Who this trial is looking for

This trial is looking for people with HIV or related brain conditions to study changes in brain cell connections. Participants will undergo brain scans and tests to understand the effects of HIV on the brain during treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have HIV and have been on medication for at least a year.
  • I have no more than one viral load test above 20 HIV RNA cps/mL in the past year.
  • I am willing to participate in brain scans and tests.
  • I am female and have a negative pregnancy test.
  • I will provide written consent to participate.
  • I am in good physical health as judged by a doctor.

You may not be able to join if

  • I have a history of major non-HIV related brain illnesses.
  • I have active substance dependence.
  • I have a bleeding disorder or take blood thinners.
  • I cannot undergo MRI scans due to implants or claustrophobia.
  • I have had recent radiation exposure that exceeds safety limits.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this study is to longitudinally characterize and evaluate changes in synaptic density in the brain using novel positron-emission tomography (PET) scans; magnetic resonance imaging (MRI), and clinical laboratory markers associated with HIV-related injury in the central nervous system. This study will test hypotheses relating to the presence and mechanisms of aberrant brain structure …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
PLWH Inclusion Criteria: * Voluntary, written, informed consent (signed and dated) * For females, a negative urine or serum pregnancy (HCG) test at screening and on each scan day before initiation of any scan procedures. * HIV infection on cART with documented viral suppression for at least one yea…
Contacts

Allison Nelson, RN

(475) 434-4324

allison.nelson@yale.edu

CONTACT

Paige Ryall

(475) 375-7424

paige.ryall@yale.edu

CONTACT